Past Podcast Episodes

As the United States begins to move past the pandemic and toward something much closer to life as we once knew it, I've received a lot of questions from members of the RealTalk MS listener community who are concerned about how their disease-modifying therapy may affect the efficacy of the COVID-19 vaccine, whether the authorized vaccines will protect them from variants, and whether they should continue wearing a mask, despite encouraging recommendations from the CDC.

Dr. Nancy Sicotte

As Chair of the National MS Society's National Medical Advisory Committee, Dr. Nancy Sicotte also leads the MS Society's COVID-19 Vaccine Advisory Group. And Dr. Sicotte is joining me once again to answer your questions and resolve some of the confusion around these important topics.

We have a lot to talk about! Are you ready for RealTalk MS??!

World MS Day is May 30th :25

Dr. Sicotte answers your questions about Vaccines and DMTs, Variants, Masks, and More 3:03

Share this episode 24:04

Have a minute? Leave a rating & review for the podcast 24:25

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/195

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society COVID-19 Vaccine Guidance for People Living with MS

FDA Advisory on Antibody Tests

World MS Day

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 195
Guests: Dr. Nancy Sicotte

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS

Privacy Policy

When Pierluigi Mantovani saw what was available to help his father rehabilitate his MS-related foot drop, he was motivated to invent something better. Pierluigi recruited a couple of friends and their efforts led to a breakthrough solution for foot drop that was declared the winner of the Lyfebulb and Bristol Myers Squibb Addressing Unmet Needs in MS: Innovation Challenge.

Pierluigi joins me as my guest this week to discuss EvoWalk, his award-winning example of innovation in MS rehabilitation.

Pierluigi Montovani

We'll also share some very unsettling realities about MS treatment that have been revealed in the latest addition to the MS International Federation's Atlas of MS.

We're checking in with an exercise coach and one of the participants in the STEP for MS trial. You'll hear about this participant's remarkable progress and we'll tell you how you can still participate in this study.

We'll tell you about a new Yale University study that's designed to determine whether Ocrevus can prevent the onset of MS in people diagnosed with radiologically isolated syndrome.

And although the oral disease-modifying therapy Ozanimod (Zeposia) has already been approved to treat relapsing-remitting MS in the U.S., Canada, and Europe, we'll update you on the decision not to approve it for use in England and Wales.

We have a lot to talk about! Are you ready for RealTalk MS??!

Atlas of MS, Part 2 Reveals Some Unsettling Truths 2:19

Zeposia fails to win approval by NICE 6:10

The Step for MS Study with Brendon Truax and Bo Roberts 8:15

Yale study will test whether Ocrevus can prevent MS in patients diagnosed with RIS 14:23

Pierluigi Mantovani discusses his father's inspiration in developing EvoWalk for rehabilitating MS foot drop 16:49

Share this episode 27:44

Have a minute? Leave a rating & review for the podcast 28:05